ferric carboxymaltose

transferrin ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33910844 Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients. 2021 May-Jun 1
2 33918110 Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients with Postoperative Anemia Following Same-Day Bilateral Total Knee Arthroplasty: A Randomized Controlled Trial. 2021 Apr 2 1
3 34079413 Ferric Carboxymaltose for Anemic Perioperative Populations: A Systematic Literature Review of Randomized Controlled Trials. 2021 1
4 34470831 Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial. 2021 Oct 1
5 31561177 The Effect of Perioperative Intravenous Iron on Hemoglobin in Surgical Patients: A Meta-Analysis. 2020 Feb 1
6 31937462 Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia. 2020 Feb 1
7 32154642 Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center. 2020 Dec 1
8 32839355 Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up. 2020 Sep 30 2
9 31197861 Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding. 2019 Aug 1
10 28701470 Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. 2017 Oct 10 1
11 27282576 Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose. 2016 Jul 1
12 25326244 Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity. 2015 Feb 2
13 23071262 Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. 2013 Feb 1
14 23078888 Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. 2013 Mar 2
15 21942989 Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. 2011 Sep 24 2
16 20648930 Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. 2010 1
17 19405553 Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. 2009 4